<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>06976055950222</udiDi>
    <basicUdiDi>697605595G0S3P0GJ</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:56.242Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950215</udiDi>
    <basicUdiDi>697605595G0L3P0EZ</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:54.629Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950208</udiDi>
    <basicUdiDi>697605595G0D3P0D9</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:53.842Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950192</udiDi>
    <basicUdiDi>697605595G0S300DM</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:52.611Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950185</udiDi>
    <basicUdiDi>697605595G0L300C4</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:49.829Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950178</udiDi>
    <basicUdiDi>697605595G0D300AC</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:48.225Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950161</udiDi>
    <basicUdiDi>697605595G0S2P0GD</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:47.432Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950154</udiDi>
    <basicUdiDi>697605595G0L2P0EU</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:45.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950147</udiDi>
    <basicUdiDi>697605595G0D2P0D4</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:43.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950130</udiDi>
    <basicUdiDi>697605595G0S200DG</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:41.819Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950123</udiDi>
    <basicUdiDi>697605595G0L200BX</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:41.029Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950116</udiDi>
    <basicUdiDi>697605595G0D200A7</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:39.421Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976055950055</udiDi>
    <basicUdiDi>697605595G0DLS0HA</basicUdiDi>
    <tradeName>Dreisam</tradeName>
    <deviceName>Continuous Glucose Monitoring Device</deviceName>
    <manufacturerName>Dreisam (Beijing) Medical Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000047458</manufacturerSrn>
    <authorisedRepresentativeName>Firsteck Bio Srl.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000039427</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z1204011502</emdnCode>
    <emdnDescription>INVASIVE BLOOD SUGAR MONITORING SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-02T17:37:37.018Z</lastUpdated>
  </row>
</eudamedExport>